Unknown

Dataset Information

0

Prognostic value of downregulated 5-hydroxymethylcytosine expression in renal cell carcinoma: a 10 year follow-up retrospective study.


ABSTRACT: 5-hydroxymethylcytosine (5hmC) is converted from DNA methylation of cytosine (5mC) by the catalysis of TET proteins, and proposed to be involved in tumorigenesis. However, the prognostic value of 5hmC in renal cell carcinoma (RCC) is still unclear. This study aimed to define the clinical significance of 5hmC in RCC. We performed dot blot assays to measure the relative expression of 5hmC in RCC. We reviewed the clinical records of 310 RCC patients and performed immunohistochemical (IHC) staining of 5hmC. The overall survival (OS) and cancer specific survival (CSS) of all patients were recorded over a 10-year follow-up period. Effective prognostic nomograms which contained 5hmC were established to provide individualized OS and CSS in RCC. 5hmC expression level was significantly decreased in RCC tissues compared with those in the normal counterparts. Kaplan-Meier curves revealed that high 5hmC expression had a good prognostic impact on RCC patients. Cox multivariate survival analyses further indicated 5hmC was an independent prognostic factor for RCC survival. Nomograms constructed based on cox regression analysis were available to calculate the survival probability directly. Calibration curves displayed good agreements. The findings were validated with an independent external cohort included 77 RCC cases. Thus, we believe we have found a significative prognostic factor for RCC.

SUBMITTER: Chen S 

PROVIDER: S-EPMC6959072 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic value of downregulated 5-hydroxymethylcytosine expression in renal cell carcinoma: a 10 year follow-up retrospective study.

Chen Song S   Zhou Qiang Q   Liu Tongzu T   Zhang Weibing W   Zeng Xian-Tao XT   Guo Zhongqiang Z  

Journal of Cancer 20200101 5


5-hydroxymethylcytosine (5hmC) is converted from DNA methylation of cytosine (5mC) by the catalysis of TET proteins, and proposed to be involved in tumorigenesis. However, the prognostic value of 5hmC in renal cell carcinoma (RCC) is still unclear. This study aimed to define the clinical significance of 5hmC in RCC. We performed dot blot assays to measure the relative expression of 5hmC in RCC. We reviewed the clinical records of 310 RCC patients and performed immunohistochemical (IHC) staining  ...[more]

Similar Datasets

| S-EPMC4559039 | biostudies-literature
| S-EPMC9311812 | biostudies-literature
| S-EPMC8193555 | biostudies-literature
| S-EPMC8824799 | biostudies-literature
| S-EPMC7443269 | biostudies-literature
| S-EPMC3111518 | biostudies-literature
| S-EPMC6748198 | biostudies-other
| S-EPMC4626242 | biostudies-literature
| S-EPMC8780570 | biostudies-literature
| S-EPMC7398100 | biostudies-literature